Restricted accessResearch articleFirst published online 2014-6
Examining relations between alpha power as well as anterior cingulate cortex-localized theta activity and response to single or dual antidepressant pharmacotherapies
Electrocortical indices may be useful in predicting antidepressant response. Greater pretreatment alpha power and high rostral anterior cingulate cortex (rACC) theta activity tend to index a favorable outcome. The predictive utility of alpha power asymmetry has been under-explored. Baseline alpha2 (10.5–13.0 Hz) power/asymmetry, rACC theta2 (6.0–8.0 Hz) activity and early (one week) changes in these measures were assessed in relation to antidepressant response by week 12 to three treatment regimens (escitalopram (ESC) + bupropion (BUP), ESC or BUP) in patients with major depressive disorder (N=51). No treatment differences in response existed at week 12. Overall, treatment responders exhibited high, and non-responders low, frontal baseline alpha2 power. Frontal alpha2 power weakly discriminated responders/non-responders overall while posterior alpha2 power and BA25-localized theta2 activity strongly discriminated ESC responders/non-responders. No associations with alpha2 asymmetry and response emerged. BUP responders exhibited high, and BUP non-responders low, baseline rACC theta2 activity. Greater early decreases in rACC theta2 activity existed in ESC+BUP non-responders versus ESC+BUP responders. BUP responders exhibited greater rACC theta2 activity decreases than ESC responders. These preliminary results indicate that baseline and early changes in alpha2 and rACC theta2 activity associate with response and have implications for tailoring antidepressant treatments.
BaresMBrunovskyMKopecekM. (2008) Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. Eur Psychiatry23: 350–355.
2.
BarnhoferTDugganDCraneC. (2007) Effects of meditation on frontal alpha-asymmetry in previously suicidal individuals. Neuroreport18: 709–712.
3.
BaskaranAMilevRMcIntyreRS (2012) The neurobiology of the EEG biomarker as a predictor of treatment response in depression. Neuropharmacology63: 507–513.
4.
BrodyALSaxenaSSilvermanDH. (1999) Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res91: 127–139.
5.
BruderGESedorukJPStewartJW. (2008) Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: Pre- and post-treatment findings. Biol Psychiatry63: 1171–1177.
6.
BruderGEStewartJWTenkeCE. (2001) Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant. Biol Psychiatry49: 416–425.
7.
ChatrianGELettichENelsonPL (1985) Ten percent electrode system for topographic studies of spontaneous and evoked EEG activity. Am J EEG Technol25: 83–92.
8.
DavidsonR (1998) Anterior electrophysiological asymmetrics, emotion, and depression: Conceptual and methodological conundrums. Psychophysiology35: 607–614.
9.
DeldinPJChiuP (2005) Cognitive restructuring and EEG in major depression. Biol Psychol70: 141–151.
10.
DrevetsWC (2000) Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res126: 413–431.
11.
FirstMBGibbonMSpitzerRL. (1997) Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II). Washington, DC: American Psychiatric Press, Inc.
12.
GrattonGColesMGDonchinE (1983) A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol55: 468–484.
13.
HagemannD (2004) Individual differences in anterior EEG asymmetry: Methodological problems and solutions. Biol Psychol67: 157–182.
14.
HamiltonM (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry23: 56–62.
15.
HunterAMCookIAGreenwaldSD. (2011) The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine. J Clin Neurophysiol28: 478–482.
16.
ItilTM (1983) The discovery of antidepressant drugs by computer-analyzed human cerebral bio-electrical potentials (CEEG). Prog Neurobiol20: 185–249.
17.
JaworskaNBlierPFuseeW. (2012) α Power, α asymmetry and anterior cingulate cortex activity in depressed males and females. J Psychiatr Res46: 1483–1491.
18.
JunghöferMElbertTTuckerDM. (1999) The polar average reference effect: A bias in estimating the head surface integral in EEG recording. Clin Neurophysiol110: 1149–1155.
19.
KnottVJTelnerJILapierreYD. (1996) Quantitative EEG in the prediction of antidepressant response to imipramine. J Affect Disord39: 175–184.
20.
KlimescheW (1999) EEG alpha and theta oscillations reflect cognitive and memory performance: A review and analysis. Brain Res Rev29: 169–195.
21.
KonarskiJZKennedySHSegalZV. (2009) Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci34: 175–180.
22.
KorbASHunterAMCookIA. (2011) Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Res192: 188–194.
23.
LaufsHKrakowKSterzerP. (2003) Electroencephalographic signatures of attentional and cognitive default modes in spontaneous brain activity fluctuations at rest. Proc Natl Acad Sci USA100: 11053–11058.
24.
LeuchterAFCookIAGilmerWS. (2009) Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res169: 132–138.
25.
LeuchterAFLesserIMTrivediMH. (2008) An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. J Psychiatr Pract14: 271–280.
26.
LinJSAnacletCSergeevaOA. (2011) The waking brain: An update. Cell Mol Life Sci68: 2499–2512.
27.
MartindaleC (1977) Creativity, consciousness and cortical arousal. J Alter St Conscious3: 69–87.
28.
MaybergHSBrannanSKMahurinRK. (1997). Cingulate function in depression: A potential predictor of treatment response. Neuroreport8: 1057–1061.
29.
MontgomerySAÅsbergS (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry134: 382–389.
30.
MulertCJuckelGBrunnmeierM. (2007) Prediction of treatment response in major depression: Integration of concepts. J Affect Disord98: 215–225.
31.
NarushimaKMcCormickLMYamadaT. (2010) Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression. J Neuropsychiatry Clin Neurosci22: 75–84.
32.
NeuperCPfurtschellerG (2001) Event-related dynamics of cortical rhythms: Frequency-specific features and functional correlates. Int J Psychophysiol43: 41–58.
33.
OakesTRPizzagalliDAHendrickAM. (2004) Functional coupling of simultaneous electrical and metabolic activity in the human brain. Hum Brain Mapp21: 257–270.
34.
OlbrichSCMulertSKarch MT. (2009) EEG-vigilance and BOLD effect during simultaneous EEG/fMRI measurement. Neuroimage45: 319–332.
35.
OldfieldRC (1971). The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia9: 97–113.
PizzagalliDPascual-MarquiRDNitschkeJB. (2001) Anterior cingulate activity as a predictor of degree of treatment response in major depression: Evidence from brain electrical tomography analysis. Am J Psychiatry158: 405–415.
38.
PizzagalliDA (2011) Frontocingulate dysfunction in depression: Toward biomarkers of treatment response. Neuropsychopharmacology36: 183–206.
39.
PizzagalliDASherwoodRJHenriquesJB. (2005) Frontal brain asymmetry and reward responsiveness: A source-localization study. Psychol Sci16: 805–813.
40.
PosternakMAZimmermanM (2007) Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: Meta-analysis. Br J Psychiatry190: 287–292.
41.
SalvadoreGCornwellBRColon-RosarioV. (2009) Increased anterior cingulate cortical activity in response to fearful faces: A neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol Psychiatry65: 289–295.
42.
SantenGDanhofMDella PasquaO (2009) Sensitivity of the Montgomery Asberg Depression Rating Scale to response and its consequences for the assessment of efficacy. J Psychiatr Res43: 1049–1056.
43.
SaxenaSBrodyALHoML. (2003) Differential brain metabolic predictors of response to paroxetine in obsessive–compulsive disorder versus major depression. Am J Psychiatry160: 522–532.
44.
SegraveRNathanP (2005) Pindolol augmentation of selective serotonin reuptake inhibitors: Accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression. Hum Psychopharmacol20: 163–174.
45.
SegraveRACooperNRThomsonRH. (2011) Individualized alpha activity and frontal asymmetry in major depression. Clin EEG Neurosci42: 45–52.
46.
StewartJLBismarkAWTowersDN. (2010) Resting frontal EEG asymmetry as an endophenotype for depression risk: Sex-specific patterns of frontal brain asymmetry. J Abnorm Psychol119: 502–512.
47.
TenkeCEKayserJMannaCG. (2011) Current source density measures of electroencephalographic alpha predict antidepressant treatment response. Biol Psychiatry70: 388–394.
48.
UlrichGHaugHJStieglitzRD. (1988) EEG characteristics of clinically defined on-drug-responders and non-responders – a comparison of clomipramine vs. maprotiline. Pharmacopsychiatry21: 367–368.
49.
UlrichGRenfordtEZellerG. (1984). Interrelation between changes in the EEG and psychopathology under pharmacotherapy for endogenous depression. A contribution to the predictor question. Pharmacopsychiatry17: 178–183.
50.
WagnerGKochKSchachtzabelC. (2010) Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression. J Psychiatry Neurosci35: 247–257.
51.
WagnerMFuchsMKastnerJ (2004) Evaluation of sLORETA in the presence of noise and multiple sources. Brain Topogr16: 277–280.
52.
WiśniewskiGJakitowiczJNowickiZ (2002) Prognostic value of pharmaco-EEG in depression treated with fluvoxamine [in Polish]. Psychiatr Pol36: 109–114.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
